Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block for Postoperative Pain in Elective Hysterectomy
NCT07139691Active, not recruiting
- Start
- Jan 2024
- Primary completion
- Jul 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine and ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms). Primary endpoints: Cumulative Opioid Consumption (Tramadol) at 24 hours and Postoperative Pain Intensity at 24 hours. Started Jan 2024; status: active, not recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07139691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07139691.